Finland· FI-REL-REL11002
Humalog Basal
A insulin lispro product, registered in Finland by Eli Lilly Nederland B.V.. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Insulin lispro is registered in 4 of 19 countries.
Countries holding a registration under ATC A10AC04 (insulin lispro), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Insulin lispro · ATC A10AC04
4 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Polandprice
The record
At a glance
Fimea (Finland)- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Finland (FI)
- ATC code
- A10AC04
- ATC class
- Insulin lispro
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for insulin lispro.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin lispro · interactions on record
434 records
- 15 severe
- 368 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10AC04
Insulin lispro, as other registers publish it.
- BelgiumHumalog 100 U/mlEli Lilly Nederland
- BelgiumHumalog 100 U/mlEli Lilly Nederland
- PolandHumalog BASALEli Lilly Nederland B.V.
- FinlandHumalog Basal KwikpenEli Lilly Nederland B.V.
- PolandHumalog BASAL KwikPenEli Lilly Nederland B.V.
- FinlandHumalog Basal PenEli Lilly Nederland B.V.
- FinlandHumalog NplEli Lilly Nederland B.V.
- FinlandHumalog Npl HumajectEli Lilly Nederland B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0d3ffdae-8054-4df3-9375-9c9f735ba1a0 GET /v1/drugs/0d3ffdae-8054-4df3-9375-9c9f735ba1a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "40",
"form": "injektioneste, suspensio, sylinteriampulli",
"route": null,
"ddd_unit": "U",
"strength": "100 U/ml",
"atc_label": "lisproinsuliini",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/96/007/10,29",
"fimea_rel_id": "REL11002",
"authorised_at": "1998-01-19"
}See everything about insulin lispro.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.